Recommended Topic Related To:

Simbrinza

"A study in mice reveals an elegant circuit within the developing visual system that helps dictate how the eyes connect to the brain. The research, funded by the National Institutes of Health, has implications for treating amblyopia, a vision diso"...

Simbrinza

Indications
Dosage
How Supplied

INDICATIONS

SIMBRINZA™ (brinzolamide/brimonidine tartrate) Ophthalmic Suspension 1%/0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

DOSAGE AND ADMINISTRATION

The recommended dose is one drop of SIMBRINZA™ in the affected eye(s) three times daily. Shake well before use. SIMBRINZA™ ophthalmic suspension may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart.

HOW SUPPLIED

Dosage Forms And Strengths

Suspension containing 10 mg/mL brinzolamide and 2 mg/mL brimonidine tartrate.

SIMBRINZA™ (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% is supplied in white low density polyethylene (LDPE) DROP-TAINER® bottles with a natural LDPE dispensing-tip and white polypropylene cap as follows:

8 mL in a 10 mL bottle NDC 0065-4147-27

Storage and Handling

Store SIMBRINZA™ at 2 - 25°C (36 - 77°F).

Alcon Laboratories, Inc. Fort Worth, Texas 76134 USA. 1-800-757-9195. alcon.medinfo@alcon.com. Revised: 04/2013

Last reviewed on RxList: 5/3/2013
This monograph has been modified to include the generic and brand name in many instances.

Indications
Dosage
How Supplied
A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.